메뉴
Assesses Tanner stage to determine if physical changes of puberty have begun (stage G2/B2 or higher) for considering pubertal suppression. Triggered when a clinician evaluates pubertal development in an adolescent patient.
기본적으로 소스를 먼저 확인하는 Prompt가 선택됩니다. 직접 명령으로 전환하거나 로컬 사본을 다운로드할 수도 있습니다.
설치 여부를 결정하기 전에 SKILL.md와 SkillsMP에 표시된 보조 파일을 읽어 보세요.
Codex 또는 Claude로 설치 이 Prompt를 복사해 Codex, Claude 또는 다른 어시스턴트에 붙여 넣으면 Skill 페이지를 검토하고 설치를 진행할 수 있습니다.
직접 명령은 검토 Prompt를 거치지 않습니다. 실행하기 전에 소스를 확인하세요.
npx skills add https://github.com/dromlakhani/MD2SKILL --skill es-determine-tanner-stage-pubertal-suppression명령은 한 줄로 유지됩니다. 복사하기 전에 가로로 스크롤해 전체 내용을 확인하세요.
로컬 사본을 원하시나요? SkillsMP에서 현재 제공할 수 있는 파일을 다운로드하세요.
SOC 직업 분류 기준
SKILL.md 표시 중
| name | es-determine-tanner-stage-pubertal-suppression |
| description | Assesses Tanner stage to determine if physical changes of puberty have begun (stage G2/B2 or higher) for considering pubertal suppression. Triggered when a clinician evaluates pubertal development in an adolescent patient. |
Obtain the patient's sex assigned at birth and perform a focused physical examination: for individuals assigned female, assess breast development using Tanner stages; for individuals assigned male, assess testicular volume and penile size using Tanner stages. Record the highest breast or genital Tanner stage observed.
Determine whether the observed Tanner stage is G2/B2 or higher. If yes, rule in that puberty has begun; if the stage remains at 1 (prepubertal), rule out puberty onset.
Classify the patient as eligible for consideration of pubertal suppression if Tanner stage is G2/B2 or higher (≥2); classify as not eligible if Tanner stage is 1.
If eligible (≥2), refer the patient to a multidisciplinary team for shared decision‑making regarding initiation of gonadotropin‑releasing hormone agonist suppression; if not eligible (stage 1), schedule a follow‑up assessment in 3 to 6 months to re‑evaluate Tanner progression.
Do not confuse adrenarche (pubic/axillary hair) with gonadarche; avoid relying solely on patient‑reported changes; be aware that obesity can mimic breast tissue in assigned females; do not delay assessment based on age alone; consider obtaining LH/FSH or ultrasensitive estradiol/testosterone if physical findings are ambiguous.
A 12‑year‑old assigned female presents with breast budding (Tanner stage 2) and no pubic hair. The clinician records Tanner stage G2, rules in puberty onset, classifies as eligible, and refers to the multidisciplinary team for discussion of GnRH agonist suppression.
Source: Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons, Endocrine Society, 2017, doi:10.1210/jc.2017-01658